Primary care physicians' attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years

Journal of Consumer Marketing

Volumn 19, Issue 7, 2002, Pages 564-574

  Paul, David P ^a   Handlin, Amy ^a   Stanton, Angela D'Auria ^b  

^a MONMOUTH UNIVERSITY   (United States)

^b JAMES MADISON UNIVERSITY   (United States)

Author keywords

Advertising; Attitudes; Consumer; Direct selling; Doctors; Drugs companies

Indexed keywords

EID: 3242714361     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760210451393     Document Type: Review

References (42)

1. Advertising Age (2001), "EU Pharmaceutical Reform Could Lead to DTC Ads", Advertising Age, July 30, p. 33.
2. Alperstein, N.M. and Peyrot, M. (1993), "Consumer awareness of prescription drug advertising", Journal of Advertising Research, Vol. 33 No. 4, pp. 50-6.
3. Appelby, J. (2001), "Prescriptions increase as drugmakers spend more on ads", USA Today, 21 February, p. 6B.
4. Bell, R.A., Kravitz, R.L. and Wilkes, M.S. (1999), "Direct-to- consumer prescription drug advertising and the public", Journal of General Internal Medicine, Vol. 14 No. 11, pp. 651-7.
5. Bercel, B., Bardelay, D. and t'Hoen, E. (1997), "A French physician's network monitoring medical representatives", La Revue Prescribe, Paris.
6. Bittar, C. (2001), "The message and the medium", Brandweek, Vol. 42 No. 28, pp. 33-8.
7. Bradley, L.R. and Zito, J.M. (1997), "Direct-to-consumer drug advertising", Medical Care, Vol. 35 No. 1, pp. 86-92.
8. Braus, P. (1998), "Selling drugs", American Demographics, Vol. 20 No. 1, pp. 26-9.
9. Cohen, E.P. (1988), "Direct-to-the-public advertisements of prescription drugs", New England Journal of Medicine, Vol. 318 No. 6, pp. 373-6.
10. Consumer Reports (1996), "Drug advertising: is this good medicine?", Consumer Reports, Vol. 61 No. 6, p. 62.
11. Dickinson, J.G. (2001), "FDA: study suggests more DTC negative info; Relenza promised too much", Medical Marketing and Media, Vol. 35 No. 3, pp. 36, 38.
12. (The) Economist (1998), "Go on, it's good for you", The Economist, No. 348, 8 August, pp. 51-2.
13. Everett, S.E. (1991), "Lay audience response to prescription drug advertising", Journal of Advertising Research, Vol. 31 No. 2, pp. 43-9.
14. Fetto, J. (2002), "Drugged out", American Demographics, Vol. 24 No. 5, p. 11.
15. Goetzl, D. (2000), "TVB study: DTC disclosures lend credibility to drug ads", Advertising Age, June 5, p. 6.
16. Gopal, K. (2002), "Consumer communication in Europe stalls: the European commission wants to open the door to DTC, but Dutch officials plan to oppose changes", Pharmaceutical Executive, Vol. 22 No. 2, pp. 38-9.
17. Handlin, A. and Paul III, D.P. (2002), "DTC advertising of Rx products: a review of the literature with suggestions for further research", in Thomas, J.L., Kellerman, B.J. and Tutor, R.K. (Eds), Proceedings of the Annual Meeting of the Association of Collegiate Marketing Educators, pp. 73-81.
18. Harris, G. (2000), "Drug firms, stymied in the lab, become marketing machines", Wall Street Journal, 6 July, pp. A1, A12.
19. Hollon, M.F. (1999), "Direct-to-consumer marketing of prescription drugs: creating consumer demand", Journal of the American Medical Association, Vol. 281 No. 4, pp. 382-4.
20. Holmer, A.F. (1999), "Direct-to-consumer prescription drug advertising builds bridges between patients and physicians", Journal of the American Medical Association, Vol. 281 No. 4, pp. 380-2.
21. Kessler, D.A. and Pines, W.L. (1990), "The Federal Regulation of prescription drug advertising and promotion", Journal of the American Medical Association, Vol. 264 No. 18, pp. 2409-15.
22. Levy, S. (1999), "What do consumers really think about DTC ads?", Drug Topics, Vol. 146 No. 3, p. 23.
23. Lexchin, J. (1997), "What information do physicians receive from pharmaceutical representatives?", Canadian Family Physician, Vol. 43 No. 4, pp. 941-5.
24. Lipsky, M.S. and Taylor, C.A. (1997), "The opinions and experiences of family physicians regarding direct-to-consumer advertising", Journal of Family Practice, Vol. 45 No. 6, pp. 495-9.
25. Lowes, R. (1999), "Doc, I saw this great new drug on TV", Medical Economics, Vol. 76, 26 April, pp. 71-6.
26. Marketing Health Services (2002) "Drug spending on the rise", Marketing Health Services, Vol. 22 No. 2, p. 10.
27. Mason, A. and Rubin, P.H. (1999), "Matching prescription drugs and consumers", New England Journal of Medicine, Vol. 313 No. 8, pp. 513-5.
28. Medical Marketing and Media (1998), "Exam time for DTC advertising, doctors 'no', consumers 'yes'", Medical Marketing and Media, Vol. 33 No. 11, pp. 24-6.
29. Medical Marketing and Media (1999), "AMA accepts the inevitable: DTC ads are here to stay", Medical Marketing and Media, Vol. 34 No. 8, p. 28.
30. Morris, L.A., Brinberg, D., Klimberg, R., Rivera, C. and Millstein, L.G. (1986), "Miscomprehension rates for prescription drug advertisements", Current Issues and Research in Advertising, Vol. 9 No. 1/2, pp. 93-113.
31. National Institute for Health Care Management and Education Foundation (2001), Prescription Drugs and Mass Media Advertising, 2000, available at: www.nihcm.org (accessed 27 November 2001).
32. Petroshius, S., Titus, P. and Hatch, K. (1995), "Physician attitudes toward pharmaceutical drug advertising", Journal of Advertising Research, Vol. 31 No. 2, pp. 43-9.
33. Pinto, M.B., Pinto, J. and Barber, J. (1998), "The impact of pharmaceutical direct advertising", Health Marketing Quarterly, Vol. 15 No. 4, pp. 89-101.
34. Pizor, T.C. (1998), "A medical published reminds us: don't forget the gatekeepers", available at: www.amponline.org/MJA/Gatekeepers.html (accessed May 2002).
35. Roth, M. (1996), "Patterns in direct-to-consumer prescription drug print advertising and their public policy implications", Journal of Public Policy and Marketing, Vol. 15, Spring, pp. 63-75.
36. Schommer, J.C., Doucette, W.R. and Mehta, B.H. (1998), "Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug", Clinical Therapeutics, Vol. 20 No. 3, pp. 617-32.
37. Sherr, M.K. and Hoffman, D.C. (1997), "Physicians gatekeepers to DTC success", Pharmaceutical Executive, October, pp. 56-66.
38. Smith, D. (1998), "Can DTC programs improve patient compliance?", DTC Times, September, pp. 14, 17.
39. t'Hoen, E. (1998), "Direct-to-consumer advertising: for better profits or for better health?", American Journal of Health-System Pharmacy, Vol. 55, pp. 594-7.
40. Wilkes, M.S., Bell, R.A. and Kravitz, R.L. (2000), "Direct-to- consumer prescription drug advertising: trends, impact, and implications", Health Affairs, Vol. 19 No. 2, pp. 110-28.
41. Wilkes, M.S., Doblin, B.H. and Shapiro, M.F. (1992), "Pharmaceutical advertisements in leading medical journals: experts' assessments", Annals of Internal Medicine, Vol. 116 No. 1, pp. 912-9.
42. Williams, J. and Hensel, P. (1995), "Direct to consumer advertising of prescription drugs", Journal of Health Care Marketing, Vol. 15 No. 1, pp. 35-41.